Patent · US Active

Anti-interleukin-33 antibodies and uses thereof

US10723795B2 · kind B2 · utility

6Cited by
13References
67Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2018
Grant dateJul 28, 2020
Priority date—
Expiry dateJan 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.